PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 146 filers reported holding PLIANT THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $86,323 | -27.9% | 8,030 | 0.0% | 0.00% | – |
| Q1 2024 | $119,647 | +18.0% | 8,030 | +43.4% | 0.00% | – |
| Q4 2023 | $101,416 | -21.5% | 5,600 | -24.9% | 0.00% | -100.0% |
| Q3 2023 | $129,252 | -4.3% | 7,454 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $135,066 | -18.4% | 7,454 | +19.7% | 0.00% | 0.0% |
| Q1 2023 | $165,585 | +37.6% | 6,225 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $120,329 | – | 6,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $78,829,000 | 19.73% |
| CHI Advisors LLC | 2,569,479 | $34,688,000 | 11.51% |
| TRV GP IV, LLC | 2,132,867 | $28,794,000 | 8.28% |
| Bond & Devick Financial Network, Inc. | 120,160 | $1,622,000 | 1.22% |
| Redmile Group, LLC | 3,083,501 | $41,627,000 | 0.95% |
| Fernwood Investment Management, LLC | 174,260 | $2,353,000 | 0.77% |
| HARVARD MANAGEMENT CO INC | 562,379 | $7,592,000 | 0.71% |
| Grace Capital | 57,471 | $776,000 | 0.46% |
| Cormorant Asset Management, LP | 482,413 | $6,513,000 | 0.39% |
| First Light Asset Management, LLC | 386,896 | $5,223,000 | 0.37% |